[PDF][PDF] The expression of vesicular glutamate transporters defines two classes of excitatory synapse
RT Fremeau, MD Troyer, I Pahner, GO Nygaard… - Neuron, 2001 - cell.com
The quantal release of glutamate depends on its transport into synaptic vesicles. Recent
work has shown that a protein previously implicated in the uptake of inorganic phosphate …
work has shown that a protein previously implicated in the uptake of inorganic phosphate …
Immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis and weak immune response after COVID-19 vaccination
…, JT Vaage, F Lund-Johansen, GO Nygaard - JAMA …, 2022 - jamanetwork.com
Methods| Patients from 3 university hospitals who were enrolled beginning on March 23,
2021, in an ongoing observational cohort study on immune responses after 2 doses of mRNA …
2021, in an ongoing observational cohort study on immune responses after 2 doses of mRNA …
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic …
…, JT Vaage, F Lund-Johansen, GO Nygaard - Journal of Neurology …, 2023 - jnnp.bmj.com
Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is
largely unknown. Understanding the development of protective immunity is of paramount …
largely unknown. Understanding the development of protective immunity is of paramount …
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
…, SM Moen, A Bjølgerudl, P Berg-Hansen, GO Nygaard… - BMC neurology, 2014 - Springer
Background Several environmental exposures, including infection with Epstein-Barr virus,
low levels of vitamin D and smoking are established risk factors for multiple sclerosis (MS). …
low levels of vitamin D and smoking are established risk factors for multiple sclerosis (MS). …
[HTML][HTML] T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
…, F Lund-Johansen, LA Munthe, GO Nygaard… - JCI insight, 2023 - ncbi.nlm.nih.gov
Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying
therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. …
therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. …
Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis
Background Fatigue and depression are frequent and often co-occurring symptoms in multiple
sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents …
sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents …
Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
GO Nygaard, H Torgauten, L Skattebøl… - Multiple Sclerosis and …, 2022 - Elsevier
… No patients in the rituximab group and seven (21.1%) in the cladribine group qualified for …
Gro Owren Nygaard reports no disclosures. Hilde Torgauten reports no disclosures. Lars …
Gro Owren Nygaard reports no disclosures. Hilde Torgauten reports no disclosures. Lars …
MR-undersøkelser ved multippel sklerose
…, HF Harbo, P Sowa, EG Celius, GO Nygaard… - Tidsskrift for den …, 2016 - tidsskriftet.no
I denne kronikken beskriver vi MR-undersøkelsene som vi anbefaler ved diagnostikk og
behandling av multippel sklerose i Norge. Multippel sklerose er en inflammatorisk og …
behandling av multippel sklerose i Norge. Multippel sklerose er en inflammatorisk og …
Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study
…, BS Winsvold, SM Moen, GO Nygaard… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background Inconsistent results have been obtained with regard to headache comorbidity
in multiple sclerosis (MS). Objective Investigate the one-year prevalence of migraine and …
in multiple sclerosis (MS). Objective Investigate the one-year prevalence of migraine and …
Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis
P Sowa, GO Nygaard, A Bjørnerud, EG Celius… - Neuroradiology, 2017 - Springer
Purpose The utility of perfusion-weighted imaging in multiple sclerosis (MS) is not well
investigated. The purpose of this study was to compare baseline normalized perfusion measures …
investigated. The purpose of this study was to compare baseline normalized perfusion measures …
